Last reviewed · How we verify
INTRALIPIDS
At a glance
| Generic name | INTRALIPIDS |
|---|---|
| Sponsor | OSF Healthcare System |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Comparison of Intralipid With SMOF Lipid Following HSCT (NA)
- Intralipid Therapy for Recurrent Implantation Failure and Recurrent Miscarriages: Is it a Hope or Myth?A Randomized Clinical Trial (PHASE4)
- Prevention of Parenteral Nutrition-Associated Cholestasis With Cyclic Parenteral Nutrition in Infants (NA)
- Tolerance of Increased Infusion Rates of Intravenous Fat Emulsions in Very Low Birth Weight Infants (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- INTRALIPIDS CI brief — competitive landscape report
- INTRALIPIDS updates RSS · CI watch RSS
- OSF Healthcare System portfolio CI